· Original article
Supermicro shares jump 12% as preliminary sales top guidance
Supermicro shares rose more than 12% premarket after preliminary fiscal Q1 revenue exceeded guidance by $4 billion, with stronger gross margins.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,089 · Page 311 / 341
· Original article
Supermicro shares rose more than 12% premarket after preliminary fiscal Q1 revenue exceeded guidance by $4 billion, with stronger gross margins.
· Original article
The Johnson Controls partnership with Armada targets 500 MW of distributed AI capacity in 2027, using factory-built facilities and NVIDIA technology.
· Original article
HII dividend rises to $1.41 per share, a 2.2% increase, with payment set for December 11, 2026, and a November 27 shareholder record date.
· Original article
Cencora acquisition values American Oncology Network at $2.4 billion, with a potential 75% stake and earnings benefits expected in year two.
· Original article
Edenred revenue was flat in Q3 2026 at €667 million. The company maintained its annual outlook despite meal-benefit regulatory changes in Italy and Brazil.
· Original article
Moody's shares fell 3% in premarket trading after Q3 earnings and revenue missed estimates, while the company kept its 2026 profit guidance unchanged.
· Original article
NVIDIA AI adoption efforts in Europe pair Jensen Huang’s Berlin appeal with data-center technology designed to reduce power and cooling demands.
· Original article
SINEXCEL recognition in the 2026 Best Under A Billion list accompanies company-reported growth figures and more than $176 million in R&D spending.
· Original article
HomeTrust buybacks gain a new 5% authorization as the bank reports stronger quarterly earnings and targets an early-2027 close for its Blue Ridge merger.
· Original article
The Ebstrocel agreement with Uniphar prepares named-patient access in Europe and MENA, while INmune Bio targets a full UK filing in February 2027.
· Original article
HomeTrust earnings rose in the third quarter of 2026, helped by higher net interest income and a tax benefit, while classified assets increased.
· Original article
Pressure ulcer devices could reach a $7.93 billion market by 2035, DataM Intelligence forecasts, as suppliers expand into monitoring and wound care.
Charts and market data by TradingView. Availability and delays vary by exchange.